PGR vs PPCB · P/E 10, rev $87.67B vs P/E 0.0, $3.9M cap
Progressive Corp (PGR) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
PPCB does not have a complete income-statement cache yet.
PGR currently screens at market cap $119.28B and trailing P/E 10.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the PGR and PPCB stock pages for the full models.
Not investment advice.